申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20160326125A1
公开(公告)日:2016-11-10
The present invention provides compounds of Formula (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used medicaments.
本发明提供了规范中定义的Formula (I)的化合物以及包含任何此类新化合物的组合物。这些化合物是内皮酶抑制剂,可用作药物。